Cibus Global Ltd. Class A
Research Cibus Global Ltd. Class A (CBUS) on Bullrun: market cap USD 109.15M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerCBUS
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 109.15M
- Financial periodFY2025
- RevenueUSD 3.64M
- Revenue growth-14.6%
- Net income-USD 127.09M
- Free cash flow-USD 51.17M
Valuation Snapshot
latest market cap is USD 109.15M.
About Cibus Global Ltd. Class A
Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-throughput gene-editing system marketed under the Trait Machine brand name. The company was formerly known as Calyxt, Inc.
Frequently asked questions
What is Cibus Global Ltd. Class A's market cap?
Cibus Global Ltd. Class A's market capitalization is USD 109.15M.
What does Cibus Global Ltd. Class A do?
Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients.